stockrow
Friday 6 November 2026
Export IOSP’s income statement to Excel — free account
Innospec Inc.
IOSP Basic Materials Specialty Chemicals
Innospec Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.8 billion, down 3.65% from fiscal 2024.
- Revenue
- +7.17%
- EPS
- +146.7%
- Free cash flow
- −88.7%
Quarter to September 2026, against a year earlier
77.67
1.46
−1.85%
Follow IOSP
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
16.80 | 16.58 | 15.87 | 16.35 |
+8 more quarters Free account |
P/S ratio |
1.25 | 1.09 | 1.01 | 1.07 | |
P/FCF ratio |
64.68 | 39.02 | 32.89 | 29.80 | |
P/Operating CF |
134.93 | 278.58 | 102.79 | 31.53 | |
P/B ratio |
1.70 | 1.48 | 1.34 | 1.43 | |
Price to Tangible BV |
2.55 | 2.26 | 2.05 | 2.20 | |
EV/Sales |
1.13 | 0.96 | 0.86 | 0.92 | |
EV/EBITDA |
11.48 | 10.43 | 9.28 | 9.44 | |
EV/Operating CF |
20.64 | 14.30 | 12.08 | 11.81 | |
EV/FCF |
58.33 | 34.58 | 28.03 | 25.56 | |
Quick Ratio |
1.84 | 1.79 | 1.92 | 1.76 | |
Current Ratio |
2.95 | 2.78 | 2.98 | 2.79 | |
Net Debt/EBITDA |
(4.91) | (5.03) | (6.23) | (7.88) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
1.03 | 1.01 | 1.00 | 1.00 | |
Operating CF/Net income |
0.55 | 0.23 | 0.58 | 1.27 | |
Capex/Depreciation |
(1.62) | (1.65) | (1.38) | 2.11 | |
Research and Development Expense of Revenue |
3.55% | 2.89% | 2.91% | 2.41% | |
Selling, General and Administrative Expense of Revenue |
15.14% | 17.16% | 17.32% | 15.21% | |
Intangible Assets out of Total Assets |
0.25 | 0.25 | 0.26 | 0.25 | |
Share Based Compensation of Revenue |
0.30% | 0.45% | 0.35% | 0.68% | |
Graham Net Nets |
0.24 | 0.26 | 0.29 | 0.27 | |
Graham Number |
84.57 | 77.82 | 75.16 | 75.11 | |
Earnings Yield |
5.95% | 6.03% | 6.30% | 6.11% | |
Free Cash Flow Yield |
1.55% | 2.56% | 3.04% | 3.36% | |
Revenue per Share |
19.23 | 19.94 | 18.29 | 18.31 | |
Operating CF per Share |
0.71 | 0.29 | 0.71 | 2.43 | |
Capex per Share |
(0.63) | (0.67) | (0.55) | (0.82) | |
Free Cash Flow per Share |
0.07 | (0.38) | 0.16 | 1.60 | |
Cash per Share |
10.23 | 10.15 | 11.67 | 11.76 | |
Shareholders Equity per Share |
56.04 | 54.82 | 54.58 | 53.57 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
56.04 | 54.82 | 54.58 | 53.57 | |
Free Cash Flow |
1.80 | (9.30) | 3.90 | 39.90 | |
Working Capital |
683.20 | 656.60 | 664.30 | 644.50 | |
Capital Expenditures |
(15.60) | (16.50) | (13.70) | (20.50) | |
Net Current Asset Value |
558.10 | 529.50 | 531.50 | 505.10 | |
EV/EBIT |
12.86 | 13.79 | 12.48 | 12.61 | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.05 | |
Price to Operating Income |
14.26 | 15.56 | 14.65 | 14.71 | |
| Other line items | |||||
Average Receivables |
372.55 | 372.35 | 348.85 | 342.00 | |
Average Payables |
163.30 | 159.40 | 154.00 | 169.25 | |
Average Inventory |
353.50 | 337.05 | 318.45 | 315.15 | |
Average Assets |
1,828.00 | 1,826.15 | 1,797.20 | 1,783.55 | |
Average Common Equity |
1,341.60 | 1,326.25 | 1,308.95 | 1,274.50 |
Columns are period end dates · fundamentals updated 6 Nov 2026